PT1149910E - Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus - Google Patents

Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus

Info

Publication number: PT1149910E
Authority: PT; Portugal
Prior art keywords: infections; papilomavirus; pharmaceutical composition; composition against; against tumors
Prior art date: 1996-07-30

Application number

PT01109013T

Other languages

English (en)

Inventor

Nadine Bizouarne

Marie-Paule Kieny

Jean-Marc Balloul

Original Assignee

Transgene Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-30

Filing date

1997-07-29

Publication date

2004-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1149910(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-07-29 Application filed by Transgene Sa filed Critical Transgene Sa

2004-09-30 Publication of PT1149910E publication Critical patent/PT1149910E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Plant Substances (AREA)

PT01109013T 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus PT1149910E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9609584A FR2751879B1 (fr)	1996-07-30	1996-07-30	Composition pharmaceutique contre les tumeurs et infections a papillomavirus

Publications (1)

Publication Number	Publication Date
PT1149910E true PT1149910E (pt)	2004-09-30

Family

ID=9494633

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT97935646T PT862634E (pt)	1996-07-30	1997-07-29	Composicao farmaceutica contra os tumores e infeccoes de papilomavirus
PT01109013T PT1149910E (pt)	1996-07-30	1997-07-29	Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT97935646T PT862634E (pt)	1996-07-30	1997-07-29	Composicao farmaceutica contra os tumores e infeccoes de papilomavirus

Country Status (12)

Country	Link
EP (2)	EP1149910B1 (pt)
JP (2)	JP4070815B2 (pt)
AT (2)	ATE205881T1 (pt)
AU (1)	AU736720B2 (pt)
CA (1)	CA2234263C (pt)
DE (2)	DE69706825T3 (pt)
DK (2)	DK0862634T4 (pt)
ES (2)	ES2215805T3 (pt)
FR (1)	FR2751879B1 (pt)
HK (1)	HK1043809B (pt)
PT (2)	PT862634E (pt)
WO (1)	WO1998004705A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7494658B2 (en)	1998-02-20	2009-02-24	Medigene Ag	Papilloma virus truncated L1 protein and fusion protein constructs
US20020039584A1 (en)	1998-02-20	2002-04-04	Medigene Ag	Papilloma virus capsomere vaccine formulations and methods of use
CA2229955C (en)	1998-02-20	2003-12-09	Medigene Gmbh	Papilloma virus capsomere vaccine formulations and methods of use
US7182947B2 (en)	1998-02-20	2007-02-27	Medigene Ag	Papillomavirus truncated L1 protein and fusion protein constructs
US6926897B1 (en)	1998-03-24	2005-08-09	Medigene Aktiengesellschaft	Medicament for the avoidance or treatment of papillomavirus-specific tumour
WO2000000217A1 (fr) *	1998-06-26	2000-01-06	Aventis Pasteur	Immunisation a ciblage mucosal
WO2007147528A1 (en)	2006-06-20	2007-12-27	Transgene S.A.	Process for producing poxviruses and poxvirus compositions
WO2010084100A1 (en)	2009-01-20	2010-07-29	Transgene Sa	Soluble icam-1 as biomarker for prediction of therapeutic response
AU2010227611B2 (en)	2009-03-24	2014-05-29	Transgene Sa	Biomarker for monitoring patients
US20120058493A1 (en)	2009-04-17	2012-03-08	Bruce Acres	Biomarker for monitoring patients
BRPI1007744A2 (pt)	2009-05-12	2017-06-27	Transgene Sa	método para a produção e purificação de um ortopoxvírus do tipo selvagem, ortopoxvírus do tipo selvagem, composição farmacêutica, uso de um ortopoxvírus do tipo selvagem e uso de uma linhagem de células aviárias imortalizadas
MX337287B (es)	2009-07-10	2016-02-22	Transgene Sa	Biomarcador para seleccionar pacientes y metodos relacionados.
US20120190100A1 (en)	2009-07-21	2012-07-26	Transgene AS	Enzymatic composition for the digestion of chicken embryos
TWI690322B (zh)	2012-10-02	2020-04-11	法商傳斯堅公司	含病毒的調配物及其使用
US10517943B2 (en)	2014-12-01	2019-12-31	Transgene S.A.	Stable liquid vaccinia virus formulations
FR3042121A1 (fr) *	2015-10-08	2017-04-14	Jean-Marc Limacher	Composition anti-tumorale
JP2020519666A (ja)	2017-05-15	2020-07-02	ヤンセンファッシンズアンドプリベンションベーフェーＪａｎｓｓｅｎＶａｃｃｉｎｅｓ＆ＰｒｅｖｅｎｔｉｏｎＢ．Ｖ．	安定性のウイルス含有組成物
AU2018270375A1 (en)	2017-05-15	2019-10-31	Bavarian Nordic A/S	Stable virus-containing composition
CA3111273C (en)	2018-09-06	2024-03-26	Bavarian Nordic A/S	Storage improved poxvirus compositions
WO2021180943A1 (en)	2020-03-12	2021-09-16	Bavarian Nordic A/S	Compositions improving poxvirus stability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2643817B1 (fr) *	1989-03-06	1993-12-17	Transgene Sa	Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
AU650868B2 (en) †	1990-03-20	1994-07-07	Behringwerke Aktiengesellschaft	Seroreactive epitopes of human papillomavirus (HPV) 16 proteins
GB9113809D0 (en) *	1991-06-26	1991-08-14	Cancer Res Campaign Tech	Papillomavirus l2 protein
DK1298211T3 (da) *	1991-07-19	2006-11-13	Univ Queensland	Polynukleotidsegment af HPV16-genom
US5618536A (en) *	1992-09-03	1997-04-08	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric papillomavirus-like particles
GB9306731D0 (en) *	1993-03-31	1993-05-26	Cancer Res Campaign Tech	Vaccines
IL113817A (en) *	1994-06-30	2001-03-19	Merck & Co Inc	Polynucleotide for vaccination against the umbilical cord virus
EP0789774A2 (en) *	1994-10-03	1997-08-20	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
GB9505784D0 (en) *	1995-03-22	1995-05-10	Lynxvale Ltd	Anti-tumour treatment
FR2749323B1 (fr) *	1996-06-04	1998-07-10	Pasteur Merieux Serums Vacc	Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique

1996
- 1996-07-30 FR FR9609584A patent/FR2751879B1/fr not_active Expired - Fee Related
1997
- 1997-07-29 JP JP50856898A patent/JP4070815B2/ja not_active Expired - Fee Related
- 1997-07-29 DE DE69706825T patent/DE69706825T3/de not_active Expired - Lifetime
- 1997-07-29 AU AU38552/97A patent/AU736720B2/en not_active Ceased
- 1997-07-29 ES ES01109013T patent/ES2215805T3/es not_active Expired - Lifetime
- 1997-07-29 DE DE69728914T patent/DE69728914T2/de not_active Expired - Lifetime
- 1997-07-29 AT AT97935646T patent/ATE205881T1/de active
- 1997-07-29 EP EP01109013A patent/EP1149910B1/fr not_active Expired - Lifetime
- 1997-07-29 DK DK97935646T patent/DK0862634T4/da active
- 1997-07-29 AT AT01109013T patent/ATE265535T1/de active
- 1997-07-29 WO PCT/FR1997/001412 patent/WO1998004705A1/fr active IP Right Grant
- 1997-07-29 PT PT97935646T patent/PT862634E/pt unknown
- 1997-07-29 DK DK01109013T patent/DK1149910T3/da active
- 1997-07-29 CA CA002234263A patent/CA2234263C/fr not_active Expired - Fee Related
- 1997-07-29 ES ES97935646T patent/ES2163795T5/es not_active Expired - Lifetime
- 1997-07-29 EP EP97935646A patent/EP0862634B2/fr not_active Expired - Lifetime
- 1997-07-29 PT PT01109013T patent/PT1149910E/pt unknown
2002
- 2002-04-30 HK HK02103266.9A patent/HK1043809B/zh not_active IP Right Cessation
2007
- 2007-03-30 JP JP2007092639A patent/JP4198735B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2234263C (fr)	2009-10-13
ATE205881T1 (de)	2001-10-15
JP2000500662A (ja)	2000-01-25
DK1149910T3 (da)	2004-08-02
JP2007254474A (ja)	2007-10-04
DE69728914T2 (de)	2005-04-07
EP0862634A1 (fr)	1998-09-09
ES2163795T3 (es)	2002-02-01
HK1043809A1 (en)	2002-09-27
DE69706825D1 (de)	2001-10-25
EP0862634B2 (fr)	2006-03-01
EP1149910B1 (fr)	2004-04-28
FR2751879A1 (fr)	1998-02-06
FR2751879B1 (fr)	1998-10-30
DE69706825T2 (de)	2002-05-02
ATE265535T1 (de)	2004-05-15
DE69728914D1 (de)	2004-06-03
CA2234263A1 (fr)	1998-02-05
JP4198735B2 (ja)	2008-12-17
PT862634E (pt)	2002-03-28
DK0862634T4 (da)	2006-05-08
EP0862634B1 (fr)	2001-09-19
HK1043809B (zh)	2004-12-03
JP4070815B2 (ja)	2008-04-02
EP1149910A1 (fr)	2001-10-31
ES2163795T5 (es)	2006-07-16
WO1998004705A1 (fr)	1998-02-05
DE69706825T3 (de)	2006-08-24
AU3855297A (en)	1998-02-20
DK0862634T3 (da)	2002-01-21
AU736720B2 (en)	2001-08-02
ES2215805T3 (es)	2004-10-16

Publication	Publication Date	Title
PT1149910E (pt)	2004-09-30	Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
UA39158C2 (uk)	2001-06-15	Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ATE525387T1 (de)	2011-10-15	Rekombinante p53 x adenovirus-konstrukte methoden und zusammensetzungen
DK0611522T3 (da)	1997-01-27	Synergistiske mikrobicide sammensætninger
DE59410380D1 (de)	2004-08-05	Endosomolytisch wirksame partikel
KR860005636A (ko)	1986-08-11	활성성분으로 스페르구알린(Spergualin)을 함유하는 주사제 조성물과 그 제조방법.
ATE214610T1 (de)	2002-04-15	Neuartige pharmazeutische verwendungen von krill- enzymen
ES2107033T3 (es)	1997-11-16	Peptidos bpc, su preparacion y su utilizacion.
HK214896A (en)	1996-12-13	Substituted diaminophtalimides and analogues
ATE92542T1 (de)	1993-08-15	Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor\|than.
EP0127124A3 (en)	1987-04-08	Compounds for treating hypertension
MY101169A (en)	1991-07-31	Novel phenylureas
DE69619530D1 (de)	2002-04-04	Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
AU6722498A (en)	1998-09-22	Disubstituted biphenyloxazolines
KR970702880A (ko)	1997-06-10	신규한 펩티드 활성 물질 및 그의 제조 방법(New Peptide Active Substance And Production Thereof)
EP0153755A3 (en)	1986-04-16	Compounds for treating hypertension
IT1197892B (it)	1988-12-21	Composizioni farmaceutiche ad attivita' cicatrizzante
RU94019328A (ru)	1996-01-20	α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ